Glenmark Pharma receives ANDA tentative approval for Regadenoson injection

Glenmark Pharma receives ANDA tentative approval for Regadenoson injection

The company stated that it continues to identify and explore external development partnerships to accelerate the growth of its existing pipeline and portfolio.

AgenciesUpdated: Monday, January 17, 2022, 02:09 PM IST
article-image
Glenmark's current portfolio consists of 172 products authorized for distribution in the U.S. marketplace. | Photo credit: Twitter

Glenmark Pharmaceuticals Inc., USA has received tentative approval by the United States Food & Drug Administration (US FDA) for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe, the generic version of Lexiscan Injection, 0.4 mg/5 mL (0.08 mg/mL), of Astellas US, Inc.

Glenmark's current portfolio consists of 172 products authorized for distribution in the U.S. marketplace.

The company stated that it continues to identify and explore external development partnerships to accelerate the growth of its existing pipeline and portfolio.

The Lexiscan injection, 0.4 mg/5 mL (0.08 mg/mL) market achieved annual sales of approximately $659.9 million, according to IQVIA sales data for the 12 month period ending November 2021.

(With inputs from ANI)

RECENT STORIES

Karur Vysya Bank Revises Lending Rates From July 7, MCLR Cut Across All Tenures

Karur Vysya Bank Revises Lending Rates From July 7, MCLR Cut Across All Tenures

Automobile Retail Sales In India Rise 5% Year-On-Year, Vehicle Segments Boom, Passenger Vehicles &...

Automobile Retail Sales In India Rise 5% Year-On-Year, Vehicle Segments Boom, Passenger Vehicles &...

Kapil Sharma Enters Business World, Opens Fancy Cafe In Canada With Wife Ginni

Kapil Sharma Enters Business World, Opens Fancy Cafe In Canada With Wife Ginni

IPO: Makers Of Solar Photovoltaic Modules Emmvee Photovoltaic Power File Papers With SEBI To Raise...

IPO: Makers Of Solar Photovoltaic Modules Emmvee Photovoltaic Power File Papers With SEBI To Raise...

IPO: SmartWorks Coworking Spaces To Raise ₹583 Crore; Open For Public Subscription From July 10 To...

IPO: SmartWorks Coworking Spaces To Raise ₹583 Crore; Open For Public Subscription From July 10 To...